Uveitis has been described as a rare adverse event of anti-TNF-α therapy, and in a retrospective study four patients were described with a co-occurrence of HS and uveitis, two with anterior uveitis, one with iridocyclitis and one with panuveitis. This evidence concerns the gene TNF and histiocytic sarcoma.